{"id":"https://openalex.org/W2107765339","doi":"https://doi.org/10.1158/1078-0432.ccr-04-2019","title":"Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer","display_name":"Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer","publication_year":2005,"publication_date":"2005-05-15","ids":{"openalex":"https://openalex.org/W2107765339","doi":"https://doi.org/10.1158/1078-0432.ccr-04-2019","mag":"2107765339","pmid":"https://pubmed.ncbi.nlm.nih.gov/15897568"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-04-2019","doi":"https://doi.org/10.1158/1078-0432.ccr-04-2019","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-04-2019","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052526230","display_name":"Michael B. Atkins","orcid":"https://orcid.org/0000-0003-3901-9924","observed_orcids":["https://orcid.org/0000-0003-3901-9924"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Atkins","raw_affiliation_strings":["1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center;","4Dana-Farber/Harvard Cancer Central Renal Cancer Program, Boston, MA; and Departments of","Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center;","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"4Dana-Farber/Harvard Cancer Central Renal Cancer Program, Boston, MA; and Departments of","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017334876","display_name":"Meredith M. Regan","orcid":"https://orcid.org/0000-0002-2428-6109","observed_orcids":["https://orcid.org/0000-0002-2428-6109"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meredith Regan","raw_affiliation_strings":["2Dana-Farber/Harvard Cancer Institute; Brigham and Women's Hospital, Harvard Medical School;","4Dana-Farber/Harvard Cancer Central Renal Cancer Program, Boston, MA; and Departments of","Dana-Farber/Harvard Cancer Institute","Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber/Harvard Cancer Institute; Brigham and Women's Hospital, Harvard Medical School;","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"4Dana-Farber/Harvard Cancer Central Renal Cancer Program, Boston, MA; and Departments of","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Institute","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007052233","display_name":"David F. McDermott","orcid":"https://orcid.org/0000-0002-2675-5095","observed_orcids":["https://orcid.org/0000-0002-2675-5095","https://orcid.org/0000-0001-6978-0867"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David McDermott","raw_affiliation_strings":["1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center;","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108518835","display_name":"James Walter Mier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Mier","raw_affiliation_strings":["1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center;","4Dana-Farber/Harvard Cancer Central Renal Cancer Program, Boston, MA; and Departments of","Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center;","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"4Dana-Farber/Harvard Cancer Central Renal Cancer Program, Boston, MA; and Departments of","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052269548","display_name":"Eric J. Stanbridge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Stanbridge","raw_affiliation_strings":["5Microbiology and","6Molecular Genetics, Irvine College of Medicine, University of California, Irvine, California","Microbiology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Microbiology and","institution_ids":[]},{"raw_affiliation_string":"6Molecular Genetics, Irvine College of Medicine, University of California, Irvine, California","institution_ids":["https://openalex.org/I204250578"]},{"raw_affiliation_string":"Microbiology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076200984","display_name":"Amanda J. Youmans","orcid":"https://orcid.org/0009-0007-1180-0731","observed_orcids":["https://orcid.org/0009-0007-1180-0731"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Youmans","raw_affiliation_strings":["1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center;","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054284633","display_name":"Philip G. Febbo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip Febbo","raw_affiliation_strings":["2Dana-Farber/Harvard Cancer Institute; Brigham and Women's Hospital, Harvard Medical School;","4Dana-Farber/Harvard Cancer Central Renal Cancer Program, Boston, MA; and Departments of","Dana-Farber/Harvard Cancer Institute","Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber/Harvard Cancer Institute; Brigham and Women's Hospital, Harvard Medical School;","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"4Dana-Farber/Harvard Cancer Central Renal Cancer Program, Boston, MA; and Departments of","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Institute","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110112941","display_name":"Melissa P. Upton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Upton","raw_affiliation_strings":["1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center;","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017403551","display_name":"Mirna Lechpammer","orcid":"https://orcid.org/0000-0002-6235-6227","observed_orcids":["https://orcid.org/0000-0002-6235-6227"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mirna Lechpammer","raw_affiliation_strings":["2Dana-Farber/Harvard Cancer Institute; Brigham and Women's Hospital, Harvard Medical School;","Dana-Farber/Harvard Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber/Harvard Cancer Institute; Brigham and Women's Hospital, Harvard Medical School;","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Institute","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210134579"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046795494","display_name":"Sabina Signoretti","orcid":"https://orcid.org/0000-0002-5000-9105","observed_orcids":["https://orcid.org/0000-0002-5000-9105"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabina Signoretti","raw_affiliation_strings":["2Dana-Farber/Harvard Cancer Institute; Brigham and Women's Hospital, Harvard Medical School;","4Dana-Farber/Harvard Cancer Central Renal Cancer Program, Boston, MA; and Departments of","Dana-Farber/Harvard Cancer Institute","Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber/Harvard Cancer Institute; Brigham and Women's Hospital, Harvard Medical School;","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"4Dana-Farber/Harvard Cancer Central Renal Cancer Program, Boston, MA; and Departments of","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Institute","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Departments of","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":38.5157,"has_fulltext":false,"cited_by_count":397,"citation_normalized_percentile":{"value":0.99861642,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":100},"biblio":{"volume":"11","issue":"10","first_page":"3714","last_page":"3721"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12412","display_name":"Enzyme function and inhibition","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbonic-anhydrase-ix","display_name":"carbonic anhydrase IX","score":1.0},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9169999957084656},{"id":"https://openalex.org/keywords/interleukin-2-therapy","display_name":"interleukin-2 therapy","score":0.9559999704360962},{"id":"https://openalex.org/keywords/tumor-response-prediction","display_name":"tumor response prediction","score":0.6029999852180481},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":0.8199999928474426},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5669999718666077},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.7009999752044678}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6879914402961731},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5834817290306091},{"id":"https://openalex.org/C57742111","wikidata":"https://www.wikidata.org/wiki/Q7168","display_name":"Histology","level":2,"score":0.5754479765892029},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5169398188591003},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.47933492064476013},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.46649169921875},{"id":"https://openalex.org/C549673821","wikidata":"https://www.wikidata.org/wiki/Q683455","display_name":"Anatomical pathology","level":3,"score":0.44613155722618103},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4294254183769226}],"mesh":[{"descriptor_ui":"D000071231","descriptor_name":"Carbonic Anhydrase IX","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002256","descriptor_name":"Carbonic Anhydrases","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-04-2019","doi":"https://doi.org/10.1158/1078-0432.ccr-04-2019","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-04-2019","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:15897568","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15897568","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G8042837658","display_name":null,"funder_award_id":"P50-CA 10194","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W186894364","https://openalex.org/W319745172","https://openalex.org/W1487317674","https://openalex.org/W1915939031","https://openalex.org/W1928193662","https://openalex.org/W1979083195","https://openalex.org/W1986634084","https://openalex.org/W1987825597","https://openalex.org/W1997296315","https://openalex.org/W2019602861","https://openalex.org/W2041315113","https://openalex.org/W2046507292","https://openalex.org/W2098136315","https://openalex.org/W2098176107","https://openalex.org/W2105829250","https://openalex.org/W2109896022","https://openalex.org/W2123914905","https://openalex.org/W2143782771","https://openalex.org/W2161472946","https://openalex.org/W2163804741","https://openalex.org/W2171469612","https://openalex.org/W2462814829","https://openalex.org/W2595387994","https://openalex.org/W2605028478","https://openalex.org/W4230861071"],"related_works":["https://openalex.org/W2228218490","https://openalex.org/W2791855345","https://openalex.org/W2163860492","https://openalex.org/W29259776","https://openalex.org/W2188364086","https://openalex.org/W2095968776","https://openalex.org/W2270972909","https://openalex.org/W2050498546","https://openalex.org/W3044339288","https://openalex.org/W2157037524"],"abstract_inverted_index":{"PURPOSE:":[0],"Renal":[1],"cancer":[2,42,57],"response":[3],"to":[4,27,65,92,131,250],"interleukin":[5],"2":[6],"(IL-2)":[7],"therapy":[8,264],"and":[9,18,29,67,75,105,110,118,126,174,216,238,265],"patient":[10],"survival":[11,168,175,242],"has":[12],"been":[13],"correlated":[14,71],"with":[15,60,72,102,155,187,206,212,226],"tumor":[16],"histology":[17],"carbonic":[19],"anhydrase":[20],"IX":[21],"(CAIX)":[22],"expression.":[23,142],"In":[24,185],"an":[25,252],"effort":[26],"confirm":[28],"expand":[30],"these":[31],"observations,":[32],"we":[33],"examined":[34],"CAIX":[35,66,141,151,183,196,218,247],"expression":[36,68,197,248],"in":[37,181,257],"pathology":[38,134,272],"specimens":[39,80,96,137],"from":[40,83,271],"renal":[41,56,258],"patients":[43,148,186,261],"who":[44],"had":[45,90,139,149,194],"previously":[46],"received":[47],"IL-2":[48],"therapy.":[49,94],"EXPERIMENTAL":[50],"DESIGN:":[51],"Paraffin-embedded":[52],"tissue":[53],"sections":[54],"of":[55,87,144,157,200,221,228,255],"were":[58,70,81,97,121],"immunostained":[59],"the":[61,132],"MN-75":[62],"monoclonal":[63],"antibody":[64],"levels":[69],"histologic":[73],"findings":[74],"clinical":[76],"outcome.":[77],"RESULTS:":[78],"Tissue":[79],"obtained":[82,270],"66":[84],"patients;":[85],"27":[86,145,222],"whom":[88],"(41%)":[89],"responded":[91],"IL-2-based":[93,263],"Fifty-eight":[95],"assessed":[98],"as":[99],"clear":[100],"cell,":[101],"56,":[103],"33,":[104],"4":[106],"having":[107],"alveolar,":[108],"granular,":[109],"papillary":[111],"features,":[112],"respectively.":[113],"Twenty-four":[114],"(36%),":[115],"31":[116],"(47%),":[117],"11":[119,199],"(17%)":[120],"classified":[122],"into":[123],"good,":[124],"intermediate,":[125],"poor":[127],"prognosis":[128,209,215],"groups":[129],"according":[130],"Upton":[133],"model.":[135],"Forty-one":[136],"(62%)":[138],"high":[140,150,182,195,217],"Twenty-one":[143],"(78%)":[146],"responding":[147],"expressing":[152],"tumors":[153],"compared":[154,225],"20":[156],"39":[158,229],"(51%)":[159],"nonresponders":[160,231],"(odds":[161,232],"ratio,":[162,233],"3.3;":[163],"P":[164,235],"=":[165,172],"0.04).":[166],"Median":[167],"was":[169,178],"prolonged":[170],"(P":[171,243],"0.04)":[173],">5":[176],"years":[177],"only":[179],"seen":[180],"expressers.":[184],"intermediate":[188,213],"pathologic":[189,208,214],"prognosis,":[190],"all":[191],"nine":[192],"responders":[193,224],"versus":[198],"22":[201],"nonresponders.":[202],"A":[203],"resultant":[204],"group":[205],"good":[207],"alone":[210],"or":[211],"contained":[219],"26":[220],"(96%)":[223],"18":[227],"(46%)":[230],"30;":[234],"<":[236,244],"0.01)":[237],"exhibited":[239],"longer":[240],"median":[241],"0.01).":[245],"CONCLUSIONS:":[246],"seems":[249],"be":[251],"important":[253],"predictor":[254],"outcome":[256],"cell":[259],"carcinoma":[260],"receiving":[262],"may":[266],"enhance":[267],"prognostic":[268],"information":[269],"specimens.":[273]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":23},{"year":2013,"cited_by_count":23},{"year":2012,"cited_by_count":28}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}